Canada markets closed

Vaxil Bio Ltd. (VXL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0350-0.0050 (-12.50%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 4.11M
Enterprise Value 2.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.61
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.13

Trading Information

Stock Price History

Beta (5Y Monthly) -3.52
52-Week Change 3-56.25%
S&P500 52-Week Change 3-7.20%
52 Week High 30.1600
52 Week Low 30.0250
50-Day Moving Average 30.0302
200-Day Moving Average 30.0527

Share Statistics

Avg Vol (3 month) 345.58k
Avg Vol (10 day) 364.16k
Shares Outstanding 5136.98M
Implied Shares Outstanding 6N/A
Float 8112.67M
% Held by Insiders 18.16%
% Held by Institutions 10.01%
Shares Short (Jul 14, 2022) 420.05k
Short Ratio (Jul 14, 2022) 40.5
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.01%
Shares Short (prior month Jun 14, 2022) 43.4k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 09, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.18%
Return on Equity (ttm)-43.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -839k
Net Income Avi to Common (ttm)-854k
Diluted EPS (ttm)-0.0060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.96M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.80
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-1.02M
Levered Free Cash Flow (ttm)-688.75k